Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M867Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M18.7EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8,700,002ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with FBT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

FBT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


FBT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Keogh, WillemSenior Officer 2016-09-08Buy338$21.28368.56view
Sardo, Vincent JamesDirector 2016-09-08Sell1,500$43.05131.61view
Larson, Douglas RobertDirector, Senior Officer 2016-09-08Sell800$8.351094.13view
Fraser, AlisonDirector or Senior Officer of Insider or Subsidiar 2016-09-08Sell12,700$10.18879.47view
Brown, ArthurDirector 2016-09-08Sell250,000$0.07142342.86view
Brewster, NormanSenior Officer 2016-09-08Sell45,000$0.03332266.67view
Darling, Neil B.T.Director 2016-09-08Buy53,500$0.2736829.63view
Porter, Brian JDirector, Senior Officer 2016-09-08Sell25,176$70.1742.1view
Marsh, John M.Director 2016-09-08Sell36,000$29.5238view
Graham, Eric JohnSenior Officer 2016-09-08Buy1,700$3.232987view

Quarterly/Annual Reports about FBT:

    News about FBT:

    Articles On GuruFocus.com
    Abbott Receives FDA Approval for Freestyle Libre Sep 30 2016 
    Himax’s Pullback Is an Opportunity Sep 30 2016 
    Halliburton Is in Good Shape Sep 30 2016 
    Betting on Chevron Makes Sense Sep 30 2016 
    Lifeway Looks Good Sep 30 2016 
    Warning Signs Identify Value Declining Companies Sep 30 2016 
    EnSync Insider Purchases 1,306,737 Shares Sep 30 2016 
    Pearson PLC's Stock Yields Over 7% Sep 30 2016 
    Dunkin’ Donuts to Release Bottled Beverages Sep 30 2016 
    Insider Slashes 65,000 Computer Science Shares Sep 30 2016 

    More From Other Websites
    How Regeneron Is Working to Maintain Eylea’s Dominance Sep 29 2016
    BioMarin to Cross $1 Billion Revenue in 2016 Sep 27 2016
    Higher Discontinuations Are among Orkambi’s Concerns Sep 26 2016
    How Ionis Pharmaceuticals’ Valuation Compares to Its Peers Sep 20 2016
    Sarepta Stock Surge Boosts Some Biotech ETFs But Not Others Sep 19 2016
    Inside the Recent Surge in Biotech ETFs Sep 14 2016
    Technicals, Politics Clash for Biotech ETFs Sep 06 2016
    How Is Incyte’s Only FDA-Approved Drug Performing? Sep 05 2016
    Clinton's Proposal To Combat Drug Price Hikes Sep 02 2016
    Biotech ETF Industry Outlook Aug 31 2016
    Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns Aug 31 2016
    United Therapeutics Makes Novel Technologies a Priority Aug 31 2016
    Biotech ETFs Back In The Spotlight Aug 30 2016
    What Should We Expect from BioMarin’s Kuvan in 2016? Aug 26 2016
    What’s BioMarin’s Expected Revenue Growth in 2016 and 2017? Aug 25 2016
    Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock? Aug 24 2016
    How Xtandi Fueled Big Pharmaceutical Interest in Medivation Aug 24 2016
    Another Endorsement for Biotech ETFs Aug 16 2016
    Biotech Breakout: Take 3 Aug 04 2016
    Big Biotech Buyout Banter Buoys IBB Aug 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)